Public Health Groups Launch Global Campaign Against Abbott Labs’ Monopoly on Critical AIDS Medicine

Groups Seek Generic Competition for Abbott’s Patented Lifesaving Treatments WASHINGTON, D.C. – Today, public health groups in a dozen countries launch a campaign to challenge Abbott Laboratories’ monopolistic hold on lopinavir+ritonavir (also known as Kaletra or Aluvia), a critical HIV/AIDS medicine. The goal is to spur competition by generic drugmakers and thereby lower the medicine’s [...]